Companies › ARDX
ARDELYX INC (ARDX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001437402 · EDGAR filings · Updated 2026-07-17
ARDELYX INC (ARDX) has reported institutional ownership of 68.6%, with 236 institutional managers holding positions valued at $1.01B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-02 — Current report (8-K) filed
- 2026-06-22 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Notice of proposed sale filed (Form 144)
- 2026-06-18 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ARDELYX INC has 236 institutional holders and institutional ownership of 68.6%.
Insider activity
Insiders reported 79 transactions (5 buys, 49 sells) across 18 reporting insiders, with a net reported value of $1.83M.
Data flags from SEC filings
Related companies
CAPRICOR THERAPEUTICS INC (CAPR) · CORVUS PHARMACEUTICALS INC (CRVS) · XENCOR INC COM (XNCR) · SMITH & NEPHEW PLC (SNN) · STAAR SURGICAL CO (STAA) · TELADOC HEALTH INC (TDOC)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.